(HealthDay)—Walmart’s Generic Drug Discount Program (GDDP), which sells many commonly used generic medications for $4 per 30-day supply, offers savings over Medicare for some generic cardiovascular medications, according to a research letter published online July 24 in the Annals of Internal Medicine. Patrick Liu, from the Yale School of Medicine in New Haven, Conn., and...
Tag: <span>Drug</span>
Post
FDA grants first approval for CA drug under new pilot programs
(HealthDay)—The U.S. Food and Drug Administration has approved Ribociclib (Kisqali) in combination with an aromatase inhibitor (AI) as an initial endocrine-based therapy for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib has also been approved with fulvestrant as initial...
Post
Newly developed therapeutic shown to combat drug addiction
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON GALVESTON, Texas – A new therapeutic may help reverse chemical imbalances made to the brain by habitual drug use and could one day help recovering drug addicts avoid future drug use. Researchers from The University of Texas Medical Branch at Galveston developed and tested a treatment on rats and...
Post
Opening up a drug delivery route — Discovery of a new vehicle peptide
TOKYO MEDICAL AND DENTAL UNIVERSITY Tokyo Medical and Dental University (TMDU) study identifies promising lead compound for delivery of therapeutically effective peptides IMAGE: THIS IS A CYCLIC DECAPEPTIDE, WHICH MIMICS THE DIMERIZATION ARM OF THE EGF RECEPTOR (EGFR), WAS PREVIOUSLY FOUND TO BE CAPTURED INTO CELLS. THE AUTHORS HAVE FOUND THE PROMISING POTENTIAL. Tokyo – In...
Post
To get around pharmacy gag rules, ask about drug costs
“Do you have prescription insurance?” It’s one of the first questions consumers hear at the pharmacy counter, and many hands over their insurance cards in the hopes of getting a good price. But sometimes using insurance can actually cost more—and even prevent the pharmacist from saying so. In this Friday, July 8, 2016 file photo, a prescription...
Post
Nanoparticles carry drug duo into the brain to fight cancer
Glioblastoma is one of the most deadly forms of cancer. Affecting the brain, those unlucky enough to receive a diagnosis don’t have many treatment options – and usually a median life expectancy of just over a year. Now, researchers at MIT have developed nanoparticles that could provide hope, crossing the blood-brain barrier and delivering two types of...
Post
‘Serendipitous’ use of antimalarial drug may have improved outcome for cancer patient
The case report discusses whether the patient’s autoimmune disease and its treatment could have contributed to achieving such a ‘striking’ response to treatment A cancer patient with advanced ovarian cancer had a “remarkable” journey to recovery that may be partially attributed to a treatment she received for a completely different disease, according to a case...
Post
Diamond ‘spin-off’ tech could lead to low-cost medical imaging and drug discovery tools
Team led by Berkeley Lab and UC Berkeley researchers exploits tiny defects in diamonds to pave the way for enhanced biological imaging and drug studies IMAGE: A MICROSCOPIC IMAGE OF DIAMOND PARTICLES WITH NITROGEN-VACANCY DEFECTS. THESE SAMPLES, WHICH EXHIBIT A TRUNCATED OCTAHEDRAL SHAPE, WERE USED IN EXPERIMENTS THAT SOUGHT NEW WAYS TO TUNE AND CONTROL It may sound...
Post
Old drug provides promising new avenue for treatment of MND
An international study led by biochemists at the University of Liverpool has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease (MND). MND is an incurable, progressive disease that attacks the nerves controlling movement so muscles no longer work. MND...
Post
UAB-led study shows drug effectiveness in reducing glucocorticoid-induced bone loss
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients UNIVERSITY OF ALABAMA AT BIRMINGHAM IMAGE: KEN SAAG BIRMINGHAM, Ala. – About one in every 100 people in the world takes glucocorticoids long term to treat immune-mediated diseases. However, glucocorticoids, such as prednisone, have a side effect — they...